Analisis Faktor-Faktor yang Mempengaruhi Kepatuhan Penggunaan Obat Pasien Diabetes Mellitus Tipe 2 di Rumah Sakit PMI Kota Bogor

Factor Analysis That Affecting Drug Complience of Type 2 Diabetes Mellitus Patients in PMI Hospital, Bogor

  • Astri Harsono Putri Program Studi Farmasi, FMIPA Universitas Pakuan, Jalan Pakuan PO Box 452, Bogor, Indonesia 16143
  • Lusi Agus Setiani Program Studi Farmasi, FMIPA Universitas Pakuan, Jalan Pakuan PO Box 452, Bogor, Indonesia 16143
  • Naufal Muharram Nurdin Fakultas Gizi Masyarakat ? Institut Pertanian Bogor

Abstract

Type 2 diabetes mellitus is insulin resistance with a relative of insulin secretion disorders. The prevalence of diabetes mellitus in Indonesia in 2000 came in fourth place by 8,4 million population and in 2030 is estimated to have increased by 2,3 million. This study aims to evaluate medication adherence and factors related to adherence in type 2 diabetes mellitus. This study uses descriptive analysis design conducted in February to March 2020 with a total 60 outpatient respondents. Respondent adherence rates were measured using the Morisky Medication Adherence Scale 8 Items (MMAS 8-Items) questionnaire. The significance of the relationship between variables with respondent compliance was measured using Chi-Square. While the dominant factor influencing the respondent?s medication adherence was measured using Binary Logistic Regression. The results of the study prove that the level of adherence of people with type 2 diabetes mellitus outpatient in the Bogor City PMI is in the category of ?moderate adherence?. Bivariate analysis results showed a significant relationship between education (p value 0,041), the amount of non-diabetic drugs (p value 0,035) and the total amount of drugs (p value 0,003) with respondent adherence. The results of multivariate analysis showed that the variable total amount of drugs was the dominant factor affecting the adherence of respondent taking medication (Odds Ratio 8,350).

References

[1] Soelistijo, S. A., dkk. 2015. Konsensus Pengelolaan dan Pencegahan Diabetes Mellitus Tipe 2 di Indonesia. Jakarta : PERKENI.
[2] Departemen Kesehatan. 2018. Fact Sheet of Diabetes. Jakarta: Kementrian Kesehatan RI.
[3] Safitri, I. N. 2013. Kepatuhan Penderita Diabetes Mellitus Tipe II ditinjau dari Locus of Control. Jurnal Ilmiah Psikologi Terapan. 2 (1) : 273-290.
[4] World Heart Organization. 2013. Adherence to Long-Term Therapies. Switzerland.
[5] Susanto, Y., Alfian, R., Riana, R., & Rusmana, I. 2017. Pengaruh Layanan Pesan Singkat Pengingat Terhadap Kepatuhan Konsumsi Obat Pasien Diabetes Mellitus Tipe 2 di Puskesmas Melati Kabupaten Kapuas. Jurnal Ilmiah Manuntung. 3 (1) : 34 - 42.
[6] Aminde, L. N., Tindong, M., Ngwasiri, C. A., Aminde, J. A., Njim, T., Fondong, A. A., & Takah, N. F. 2019. Adherence to Antidiabetic Medication and Factors Associated with Non-adherence Among Patients with Type 2 Diabetes Mellitus in Two Regional Hospitals in Cameroon. BMC Endocrine Disorders. 35 (19) : 1-9.
[7] Srisartika, V. M., Cahya, A. D., & Hardiati, S. R. 2016. Analisis Faktor yang Mempengaruhi Kepatuhan Penggunaan Obat Pasien Diabetes Mellitus Tipe 2. Jurnal Manajemen dan Pelayanan Farmasi. 3 (6) : 205 - 212.
[8] Christin Beactrix, R. 2013. Analisis Drug Related Problem (DRP) pada Penderita Rawat Inap dengan Diagnosa DM Tipe 2 dengan Stroke Iskemik di Rumah Sakit "X" Sidoarjo. Jurnal Ilmiah Mahasiswa Universitas Surabaya. 2 (2).
[9] Tegar, F. 2014. Gambaran Kepatuhan Minum Obat Antidiabetes dan Antihipertensi pada Pasien Diabetes Mellitus disertai Hipertensi di Klinik Kesehatan Gereja St. Servarius Bekasi. Fakultas Kedokteran
[10] Nanda, O. D., Wiryanto, R. B., & Triyono, A. E. 2018. Hubungan Kepatuhan Minum Obat Anti Diabetik dengan Regulasi Kadar Gula Darah pada Pasien Perempuan Diabetes Mellitus. Jurnal Kesehatan Masyarakat. 340 - 348.
[11] Julaiha, S. 2019. Analisis Faktor Kepatuhan Berobat Berdasarkan Skor MMAS-8 pada Pasien Diabetes Mellitus Tipe 2. Jurnal Kesehatan. 2 (10) : 203 - 214.
[12] American, D. A. 2017. Diabetes Care The Journal of Clinical and Aplied Research and Education: Standar of Medical Care in Diabetes.
[13] Rasdianah, N., Martodiharjo, S., Andayani, T. M., & Hakim, L. 2016. Gambaran Kepatuhan Pengobatan Pasien Diabetes Mellitus Tipe 2 di Puskesmas Daerah Istimewa Yogyakarta. Jurnal Farmasi Klinik Indonesia. 4 (5) : 249 - 257.
[14] Departemen Kesehatan. 2014. Pedoman Umum Tata Kelola Baik BPJS Kesehatan. Jakarta: Kementrian Kesehatan RI.
[15] Yuliani, F., Oenzil, F., & Iryani, D. 2014. Hubungan Berbagai Faktor Resiko terhadap Kejadian Penyakit Jantung Koroner pada Penderita Diabetes Mellitus Tipe 2. Jurnal Kesehatan Andalas. 3 (1) : 37-40.
[16] Hannan, M. 2013. Analisis Faktor yang Mempengaruhi Kepatuhan Minum Obat pada Pasien Diabetes Mellitus di Puskesmas Bluto Sumenep. Jurnal Kesehatan Wiraja Medika. 1-9.
[17] Anita, S. A., Gupta, E., Prakash, A., & Singhal, N. 2019. Self-reported Adherence to Medication among Patients with Type II Diabetes Mellitus attending a Tertiary Care Hospital of Delhi. Journal of Associatin of Physicians of India. 67: 26-29.
[18] Salistyaningsih, W., Puspitawati, T., & Nugroho, D. 2011. Hubungan Tingkat Kepatuhan Minum Obat Hipoglikemik Oral dengan Kadar Glukosa Darah pada Pasien DM Tipe 2. Jurnal Kedokteran Masyarakat. 27 (4) : 215-21.
[19] Sucipto, A., & Rosa, E. M. 2016. Efektivitas Konseling DM dalam Meningkatkan Kepatuhan dan Pengendalian Gula Darah pada Diabetes Mellitus Tipe 2. Jurnal Keperawatan Muhammadiyah. 9-20.
[20] Bagonza, James, Rutebemberwa, Elizens, & Bazeyo, W. 2015. Adherence to Anti Diabetic Medication among Patients with Diabetes in Eastern Uganda; a Cross-sectional Study. BMC Health Service Research, 15 ; 1-7.
[21] Mokolomban, C., Wiyono, W. I., & Mpila, D. A. 2018. Kepatuhan Minum Obat pada Pasien Diabetes Mellitus Tipe 2 Disertai Hipertensi dengan Menggunakan Metode MMAS-8. Jurnal Ilmiah Farmasi. 4 (7) : 69 - 78.
Published
2021-04-10
How to Cite
Putri, A. H., Setiani, L. A., & Nurdin, N. M. (2021). Analisis Faktor-Faktor yang Mempengaruhi Kepatuhan Penggunaan Obat Pasien Diabetes Mellitus Tipe 2 di Rumah Sakit PMI Kota Bogor. Proceeding of Mulawarman Pharmaceuticals Conferences, 13(1), 41-48. https://doi.org/10.25026/mpc.v13i1.441